Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

References

• Adamo M, Raizada MK, LeRoith D. (1989). Insulin and insulin-like growth factor receptors in the nervous system. Mol Neurobiol, 3, 71–100.
   PubMed Web of Science ®Google Scholar
• Alyautdin RN, Petrov VE, Langer K, Berthold A, Kharkevich DA, Kreuter J. (1997). Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res, 14, 325–328.
   PubMed Web of Science ®Google Scholar
• Alyautdin RN, Tezikov EB, Ramge P, Kharkevich DA, Begley DJ, Kreuter J. (1998). Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J Microencapsul, 15, 67–74.
   PubMed Web of Science ®Google Scholar
• Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J. (2006). Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J Microencapsul, 23, 582–592.
   PubMed Web of Science ®Google Scholar
• Banks WA. (2004). The source of cerebral insulin. Eur J Pharmacol, 490, 5–12.
   PubMed Web of Science ®Google Scholar
• Begley DJ. (1994). Peptides and the blood-brain barrier: the status of our understanding. Ann N Y Acad Sci, 739, 89–100.
   PubMed Web of Science ®Google Scholar
• Boado RJ, Zhang Y, Pardridge WM. (2006). “Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.” Biotechnol Bioeng, 96, 381–91.
   Web of Science ®Google Scholar
• Burger PC, Green SB. (1987). Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer, 59, 1617–1625.
   PubMed Web of Science ®Google Scholar
• Chen H, Gaul F, Guo D, Maycock A. (2000). Determination of loperamide in rat plasma and bovine serum albumin by LC. J Pharm Biomed Anal, 22, 555–561.
   PubMed Web of Science ®Google Scholar
• Frittitta L, Cerrato A, Sacco MG, Weidner N, Goldfine ID, Vigneri R. (1997). The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice. Breast Cancer Res Treat, 45, 141–147.
   PubMed Web of Science ®Google Scholar
• Havrankova J, Roth J, Brownstein M. (1978). Insulin receptors are widely distributed in the central nervous system of the rat. Nature, 272, 827–829.
   PubMed Web of Science ®Google Scholar
• Hekmatara T, Bernreuther C, Khalansky AS, Theisen A, Weissenberger J, Matschke J, Gelperina S, Kreuter J, Glatzel M. (2009). Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects. Clin Neuropathol, 28, 153–164.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev, 47, 65–81.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Gelperina S. (2008). Use of nanoparticles for cerebral cancer. Tumori, 94, 271–277.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. (2002). Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target, 10, 317–325.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Hekmatara T, Dreis S, Vogel T, Gelperina S, Langer K. (2007). Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. J Control Release, 118, 54–58.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, McGurk SL, Liversidge GG. (2004). Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin. Pharm Res, 21, 1545–1553.
   PubMed Web of Science ®Google Scholar
• Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K. (2006). Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther, 317, 1246–1253.
   PubMed Web of Science ®Google Scholar
• Needleman LA, McAllister AK. (2008). Seeing the light: insulin receptors and the CNS. Neuron, 58, 653–655.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2004). Intravenous, non-viral RNAi gene therapy of brain cancer. Expert Opin Biol Ther, 4, 1103–1113.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2007). shRNA and siRNA delivery to the brain. Adv Drug Deliv Rev, 59, 141–152.
   PubMed Web of Science ®Google Scholar
• Petri B, Bootz A, Khalansky A, Hekmatara T, Müller R, Uhl R, Kreuter J, Gelperina S. (2007). Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release, 117, 51–58.
   PubMed Web of Science ®Google Scholar
• Plum L, Schubert M, Brüning JC. (2005). The role of insulin receptor signaling in the brain. Trends Endocrinol Metab, 16, 59–65.
   PubMed Web of Science ®Google Scholar
• Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, Severin SE, Uhl R, Kock M, Geiger KD, Gelperina SE. (2004). Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer, 109, 759–767.
   PubMed Web of Science ®Google Scholar
• Trotta M, Cavalli R, Carlotti ME, Battaglia L, Debernardi F. (2005). Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique. Int J Pharm, 288, 281–288.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmatara T, Herbert E, Kreuter J. (2009). Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm, 71, 251–256.
   PubMed Web of Science ®Google Scholar
• Wartlick H, Michaelis K, Balthasar S, Strebhardt K, Kreuter J, Langer K. (2004). Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. J Drug Target, 12, 461–471.
   PubMed Web of Science ®Google Scholar
• Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Büchel C, von Briesen H, Kreuter J. (2009). Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release, 137, 78–86.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Boado RJ, Pardridge WM. (2003). Marked enhancement in gene expression by targeting the human insulin receptor. J Gene Med, 5, 157–163.
   PubMed Web of Science ®Google Scholar